People with type 2 diabetes (T2D) using diuretics are at an increased risk of serious problems in their lower limbs that can lead to amputation, accor...
Diabetes and Endo
High prolactin level provides protection against diabetes in women
A normally high circulating total prolactin concentration in women is associated with a lower risk for type 2 diabetes, shows a new study published in...
Its possible to prevent development of diabetes: Study
The normal functioning of the insulin-producing beta cells in case of type 2 diabetes (T2D) can be restored by blocking a protein called VDAC1, the re...
Planned intermittent fasting may reverse type 2 diabetes
A new of its kind study suggests that planned intermittent fasting may help to reverse type 2 diabetes. The researchers reported an observational stud...
Very tight glycemic control in gestational diabetes not beneficial
Very tight glycemic control does not improve pregnancy outcomes for women with gestational diabetes, according to the findings of a Russian study pres...
Gastric banding as effective as metformin in stabilizing diabetes
According to a new study, Gastric banding as effective as metformin in slowing prediabetes, type two diabetes. People with prediabetes or new-onset ty...
Early signs of Diabetes detectable 20 years before diagnosis
According to a new study, Diabetes can begin 20 years before diagnosis i.e early signs of Diabetes detectable 20 years before diagnosis. The new resea...
Lorcaserin prevents Diabetes in overweight individuals
Lorcaserin decreases risk for incident diabetes, induces remission of hyperglycemia, and reduces the risk of microvascular complications in obese and ...
Routine hormone therapy has no benefit in subclinical Hypothyroidism
A new study published in the JAMA Network finds that the use of thyroid hormone therapy was not associated with improvements in general quality of lif...
lixisenatide prevents kidney damage in diabetes with CVD
According to a post-hoc analysis of the Evaluation of Lixisenatide in Acute Coronary Syndrome (ELIXA) trial, injectable glucagon-like peptide (GLP-1)...
